Bank of New York Mellon’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14
| Closed | -$9.72K | – | 4394 |
|
|
2023
Q3 | $9.72K | Hold |
14
| – | – | ﹤0.01% | 4290 |
|
|
2023
Q2 | $63.2K | Hold |
14
| – | – | ﹤0.01% | 4128 |
|
|
2023
Q1 | $36.5K | Hold |
14
| – | – | ﹤0.01% | 4241 |
|
|
2022
Q4 | $35.9K | Hold |
14
| – | – | ﹤0.01% | 4283 |
|
|
2022
Q3 | $54K | Hold |
14
| – | – | ﹤0.01% | 4306 |
|
|
2022
Q2 | $37K | Sell |
14
-62
| -82% | -$164K | ﹤0.01% | 4409 |
|
|
2022
Q1 | $244K | Hold |
76
| – | – | ﹤0.01% | 4134 |
|
|
2021
Q4 | $475K | Buy |
76
+12
| +19% | +$75K | ﹤0.01% | 3839 |
|
|
2021
Q3 | $588K | Buy |
64
+19
| +42% | +$175K | ﹤0.01% | 3715 |
|
|
2021
Q2 | $454K | Buy |
45
+38
| +543% | +$383K | ﹤0.01% | 3809 |
|
|
2021
Q1 | $128K | Sell |
7
-5
| -42% | -$91.4K | ﹤0.01% | 4131 |
|
|
2020
Q4 | $73K | Buy |
+12
| New | +$73K | ﹤0.01% | 4113 |
|
|
2018
Q1 | – | Hold |
0
| – | -$21K | – | 4405 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4285 |
|
|
2016
Q4 | – | Hold |
0
| – | -$21K | – | 4315 |
|
|
2016
Q3 | – | Hold |
0
| – | -$29K | – | 4214 |
|
|
2016
Q2 | – | Hold |
0
| – | -$42K | – | 4244 |
|
|
2016
Q1 | – | Hold |
0
| – | -$71K | – | 4100 |
|
|
2015
Q4 | – | Hold |
0
| – | -$105K | – | 4094 |
|
|
2015
Q3 | – | Hold |
0
| – | -$123K | – | 4048 |
|
|
2015
Q2 | – | Hold |
0
| – | -$118K | – | 3999 |
|
|
2015
Q1 | – | Hold |
0
| – | -$50K | – | 4005 |
|
|
2014
Q4 | – | Hold |
0
| – | -$76K | – | 4124 |
|
|
2014
Q3 | – | Hold |
0
| – | -$113K | – | 4102 |
|
|
2014
Q2 | – | Hold |
0
| – | -$106K | – | 3970 |
|
|
2014
Q1 | – | Hold |
0
| – | -$131K | – | 3954 |
|
|
2013
Q4 | – | Hold |
0
| – | -$109K | – | 3915 |
|
|
2013
Q3 | – | Hold |
0
| – | -$141K | – | 3895 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3824 |
|